In the K14-Cre-Brca1f/fTrp53f/f TNBC model, the combination of PARPi and STING agonist not only clears tumors and promotes mouse survival, but also contributes to the development of immunologic memory, the latter of which is validated via re-implanting tumors into mice with complete tumor clearance [173]. Here, STING1 is linked to neoplasm.